Circulating tumor cells (CTCs) are the seeds of distant metastasis, and the number of CTCs
detected in the blood of cancer patients is associated with a worse prognosis. CTCs face …

Pancreatic cancer is a deadly disease with high mortality due to difficulties in its early
diagnosis and metastasis. The tumor microenvironment induced by interactions between …

Pancreatic cancer (PC) is a fatal disease with high malignancy and difficult for early
diagnosis. PC causes more than 400,000 patient deaths world widely and becomes the …

Pancreatic ductal adenocarcinoma (PDAC) lethality is due to metastatic dissemination.
Characterization of rare, heterogeneous circulating tumor cells (CTCs) can provide insight …

Pancreatic cancer is a lethal condition with a rising incidence and often presents at an
advanced stage, contributing to abysmal five-year survival rates. Unspecific symptoms and …

Pancreatic ductal adenocarcinoma (PDAC) can be treated with surgery, chemotherapy, and
radiotherapy. Despite medical progress in each field in recent years, it is still insufficient for …

Cancer is considered as the leading cause of death and the major barrier of longevity
globally. The high mortality of cancer is due to the malignant spread. However, if the disease …

Pancreatic ductal adenocarcinoma (PDAC) is the most frequent pancreatic cancer type,
characterized by a dismal prognosis due to late diagnosis, frequent metastases, and limited …

While great strides in improving survival rates have been made for most cancers in recent
years, pancreatic ductal adenocarcinoma (PDAC) remains one of the solid tumors with the …

Pancreatic cystic neoplasms (PCNs) are a heterogeneous group with varying risks of
malignancy. To explore the clinical utility of liquid biopsy in cyst type classification, we …